‘Top 5’ listed pharmas in R&D ratio to sales were ISU Abxis, Celltrion, Hanmi, Bukwang, Pharmicell

Published: 2017-04-11 14:55:57

Updated: 2017-04-11 14:55:57

It was observed KOSDAQ listed pharmaceutical companies recorded a 3-times higher average growth rate of R&D expenses than the one in the KOSPI. When it comes to its ratio to sales, KOSDAQ listed pharmaceutical companies exceeded 10% while KOSPI listed pharmaceutical companies got only close to 10%.

According to the Yakup Shinmoon’s(www.yakup.com) analysis result of 37 KOSPI and 30 KOSDAQ liste...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.